Mehdwan says MoU to support Indian healthtechs
The Department for Promotion of Industry and Internal Trade (DPIIT) has signed a Memorandum of Understanding (MoU) with Roche Products (India) Pvt Ltd to bolster DPIIT-recognized startups working in critical therapeutic areas such as oncology, neurology, ophthalmology, haematology and rare diseases https://www.commerce.gov.in/.
Under the MoU, Roche India will provide mentorship from global experts, support pilot and validation studies, and offer access to cutting-edge technologies, infrastructure, and international platforms to help scale promising innovations.
The MoU was formally signed by DPIIT Director Dr Sumeet Jarangal and Managing Director, Roche Products (India) Pvt Ltd, Rajwinder Mehdwan, in the presence of senior officials from both organizations.
Joint Secretary Sanjiv highlighted the importance of industry–startup collaboration in integrating disruptive health innovations into the market, and pointed out that the partnership with Roche would offer guidance on regulatory pathways, intellectual property, and global health standards, along with opportunities for real-world validation https://www.nseindia.com/.
Capacity-building in Health Economics and Outcomes Research (HEOR), Good Clinical Practices (GCP), and patient engagement will also be a key focus area.
Mehdwan described the MoU as the beginning of a collaborative journey to support Indian healthtech startups in developing patient-centric solutions tailored to India’s healthcare needs https://www.bseindia.com/.
This MoU underscores DPIIT’s commitment to fostering impactful public-private partnerships that promote inclusive growth and position India as a global hub for health innovation, DPIIT said on 31 July. Fiinews.com
